The content on this site is intended for healthcare professionals only
Dr David Gómez-Almaguer talks to ecancer about the issues faced when treating multiple myeloma in low-resource settings in Latin America.
He explores the obstacles associated with delayed diagnoses, limited access to technology and medications.
Dr Gómez-Almaguer continues to talk about potential solutions and offers recommendations tailored to doctors practising in Low and Middle-Income Countries
Additionally, he details the accessibility of CAR-T cell therapy and highlights the potential of political and financial aid.
To conclude, Dr. Gómez-Almaguer shares his insights on recommended supportive therapy approaches.
Prostate cancer
Breast cancer
Equitable access to affordable essential oncology medicines in low- and middle-income countries
Clinical Research Mentorship Program for LMICs
CDK-4/6 inhibitors with endocrine treatment for metastatic breast cancer
ASCO's strategic plan for cancer care in LMICs
Gender inequity in ovarian cancer research in resource limited settings
Synthetic biology and precision medicine in blood and gynaecological cancers
Introducing oncology to undergraduate medical and allied health sciences students
